A number of other analysts have also recently commented on GCO. Buckingham Research lifted their price target on Genesco from $23.00 to $30.00 and gave the stock a neutral rating in a research report on Monday, November 20th. Susquehanna Bancshares reaffirmed a hold rating and set a $30.00 price target on shares of Genesco in a research report on Tuesday, November 28th. TheStreet cut Genesco from a c- rating to a d rating in a research report on Friday, December 1st. Zacks Investment Research cut Genesco from a hold rating to a sell rating in a research report on Tuesday, December 5th. Finally, ValuEngine cut Genesco from a buy rating to a hold rating in a research report on Sunday, December 31st. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the company’s stock. Genesco has an average rating of Hold and a consensus target price of $39.40.
Shares of Genesco (GCO) traded up $0.90 on Thursday, reaching $39.85. The company’s stock had a trading volume of 780,923 shares, compared to its average volume of 427,257. Genesco has a 12 month low of $20.90 and a 12 month high of $59.75. The company has a current ratio of 2.31, a quick ratio of 0.47 and a debt-to-equity ratio of 0.29. The firm has a market cap of $806.48, a PE ratio of -6.22, a P/E/G ratio of 1.21 and a beta of 1.11.
Genesco (NYSE:GCO) last issued its quarterly earnings results on Thursday, March 15th. The company reported $2.15 EPS for the quarter, topping the Zacks’ consensus estimate of $2.09 by $0.06. Genesco had a positive return on equity of 6.93% and a negative net margin of 4.24%. The company had revenue of $930.00 million during the quarter, compared to analysts’ expectations of $902.00 million. During the same quarter in the previous year, the firm posted $2.15 EPS. The firm’s revenue was up 5.3% compared to the same quarter last year. equities research analysts predict that Genesco will post 3.07 EPS for the current fiscal year.
Several hedge funds have recently modified their holdings of the company. BlackRock Inc. lifted its holdings in shares of Genesco by 4.2% in the 4th quarter. BlackRock Inc. now owns 2,534,649 shares of the company’s stock valued at $82,376,000 after buying an additional 102,787 shares during the period. Carillon Tower Advisers Inc. acquired a new position in shares of Genesco in the 4th quarter valued at about $42,811,000. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Genesco by 0.4% in the 3rd quarter. Fuller & Thaler Asset Management Inc. now owns 909,846 shares of the company’s stock valued at $24,202,000 after buying an additional 3,578 shares during the period. Legion Partners Asset Management LLC acquired a new position in shares of Genesco in the 4th quarter valued at about $26,777,000. Finally, Victory Capital Management Inc. lifted its holdings in shares of Genesco by 1.8% in the 4th quarter. Victory Capital Management Inc. now owns 552,829 shares of the company’s stock valued at $17,967,000 after buying an additional 9,744 shares during the period. 99.24% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: “Genesco (GCO) Given a $44.00 Price Target by Piper Jaffray Companies Analysts” was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://ledgergazette.com/2018/03/16/genesco-gco-given-a-44-00-price-target-by-piper-jaffray-companies-analysts.html.
Genesco Inc is a retailer and wholesaler of footwear, apparel and accessories. The Company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group and Licensed Brands. It relies on independent third-party manufacturers for production of its footwear products sold at wholesale.
Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.